文献速递临床试验与 GCP流行病学与生物统计医学人工智能与信息学

使用PIERS-ML与fullPIERS模型连续预测子痫前期不良母体结局:一项多国前瞻性观察研究

Consecutive prediction of adverse maternal outcomes of preeclampsia, using the PIERS-ML and fullPIERS models: A multicountry prospective observational study.
PubMed 文献 · PLoS Med · 2025-02-04

该多国前瞻性研究纳入8843例子痫前期孕妇,评估PIERS-ML与fullPIERS模型在入院后2周内逐日连续预测不良母体结局的表现。两模型对不良结局组的平均风险始终高于无并发症组,但区分能力随时间下降:PIERS-ML的AUC-PRC在入住当天达峰值0.65后明显下降,fullPIERS的AUC-PRC维持在0.2-0.4低位;决策曲线显示两模型指导治疗的净获益随时间递减。作者建议连续预测时更加谨慎,随妊娠进展对预测结果的不确定性递增进行解读。

要点

  • PIERS-ML与fullPIERS模型对不良结局组的平均风险始终高于无并发症组。
  • PIERS-ML的AUC-PRC在入住当天达峰值0.65后明显下降,fullPIERS的AUC-PRC维持在0.2-0.4低位。
  • PIERS-ML对「极高」风险组规则纳入能力好(阳性似然比70.99至无穷大),对「极低」风险组规则排除能力好(多数阴性似然比为0),但48小时后其他风险组表现明显下降。

核心结论

  • 两模型连续预测性能随时间下降,作者建议连续预测时更加谨慎,随妊娠进展对预测结果的不确定性递增进行解读。
  • 作者建议模型应经过调整以在连续使用时保持准确性,未来模型的性能可与本研究结果比较以量化其附加价值。

研究设计与样本

  • 多国前瞻性观察研究,纳入8843例子痫前期孕妇,中位年龄31岁,白人占32%、黑人占30%、亚裔占26%。
  • 孕妇于2003年至2016年间入住美洲、撒哈拉以南非洲、南亚、欧洲和大洋洲的产科单位,中位诊断孕周为35.79周。
  • 在入院后2周窗口内逐日评估PIERS-ML与fullPIERS模型的风险区分性能。

主要发现

  • 2周窗口内每日结局事件数从超过200例降至约10例。
  • 两模型对不良结局组的平均风险始终高于无并发症组。
  • fullPIERS的AUC-PRC为0.2-0.4,接近每日不良结局比例,提示区分能力低。
  • PIERS-ML的AUC-PRC在入住当天达峰值0.65,此后明显下降。
  • PIERS-ML对「极高」风险组的阳性似然比为70.99至无穷大,对「极低」风险组多数阴性似然比为0,但48小时后其他风险组表现明显下降;决策曲线显示两模型指导治疗的净获益随时间递减。

关键数值与推荐

  • PIERS不良母体结局包括死亡、终末器官并发症(心呼吸、肾脏、肝脏等)或子宫胎盘功能障碍(如胎盘早剥)中的一项或多项。
  • 主要结局指标为无并发症组与不良结局组的平均风险轨迹、每日精确率-召回率曲线下面积(AUC-PRC)、决策曲线分析中的净获益、多个风险组的动态变化及每日似然比。

临床怎么用

  • 作者建议连续预测时更加谨慎,随妊娠进展对预测结果的不确定性递增进行解读。
  • 作者建议模型应经过调整以在连续使用时保持准确性。

局限性

  • PIERS-ML模型的基线性能是在其开发数据上评估的,但其基线性能也已经过外部评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia is a potentially life-threatening pregnancy complication. Among women whose pregnancies are complicated by preeclampsia, the Preeclampsia Integrated Estimate of RiSk (PIERS) models (i.e., the PIERS Machine Learning [PIERS-ML] model, and the logistic regression-based fullPIERS model) accurately identify individuals at greatest or least risk of adverse maternal outcomes within 48 h following admission. Both models were developed and validated to be used as part of initial assessment. In the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommends repeated use of such static models for ongoing assessment beyond the first 48 h. This study evaluated the models' performance during such consecutive prediction. METHODS AND FINDINGS: This multicountry prospective study used data of 8,843 women (32% white, 30% black, and 26% Asian) with a median age of 31 years. These women, admitted to maternity units in the Americas, sub-Saharan Africa, South Asia, Europe, and Oceania, were diagnosed with preeclampsia at a median gestational age of 35.79 weeks between year 2003 and 2016. The risk differentiation performance of the PIERS-ML and fullPIERS models were assessed for each day within a 2-week post-admission window. The PIERS adverse maternal outcome includes one or more of: death, end-organ complication (cardiorespiratory, renal, hepatic, etc.), or uteroplacental dysfunction (e.g., placental abruption). The main outcome measures were: trajectories of mean risk of each of the uncomplicated course and adverse outcome groups; daily area under the precision-recall curve (AUC-PRC); potential clinical impact (i.e., net benefit in decision curve analysis); dynamic shifts of multiple risk groups; and daily likelihood ratios. In the 2 weeks window, the number of daily outcome events decreased from over 200 to around 10. For both PIERS-ML and fullPIERS models, we observed consistently higher mean risk in the adverse outcome (versus uncomplicated course) group. The AUC-PRC values (0.2-0.4) of the fullPIERS model remained low (i.e., close to the daily fraction of adverse outcomes, indicating low discriminative capacity). The PIERS-ML model's AUC-PRC peaked on day 0 (0.65), and notably decreased thereafter. When categorizing women into multiple risk groups, the PIERS-ML model generally showed good rule-in capacity for the "very high" risk group, with positive likelihood ratio values ranging from 70.99 to infinity, and good rule-out capacity for the "very low" risk group where most negative likelihood ratio values were 0. However, performance declined notably for other risk groups beyond 48 h. Decision curve analysis revealed a diminishing advantage for treatment guided by both models over time. The main limitation of this study is that the baseline performance of the PIERS-ML model was assessed on its development data; however, its baseline performance has also undergone external evaluation. CONCLUSIONS: In this study, we have evaluated the performance of the fullPIERS and PIERS-ML models for consecutive prediction. We observed deteriorating performance of both models over time. We recommend using the models for consecutive prediction with greater caution and interpreting predictions with increasing uncertainty as the pregnancy progresses. For clinical practice, models should be adapted to retain accuracy when deployed serially. The performance of future models can be compared with the results of this study to quantify their added value.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Yang G, Montgomery-Csobán T, Ganzevoort W, et al. Consecutive prediction of adverse maternal outcomes of preeclampsia, using the PIERS-ML and fullPIERS models: A multicountry prospective observational study. PLoS Med. 2025. PMID: 39903757. doi:10.1371/journal.pmed.1004509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。